Clinical trial Recruiting at 1 site Observational Ages 18 to 75

Single-Port SHURUI Robotic Thoracic Surgery

Official title: Thoracic Surgery by SHURUI Single-Port Surgical Robot: A Prospective Single Centre Study

Run by Chinese University of Hong Kong · NCT07255703 · Data updated 2026-11-12

This observational study tests the SHURUI single-port robotic system during thoracic surgery to see if it can reduce trauma and speed recovery in adults needing lung or mediastinal procedures.

Quick facts

Study typeObservational
Ages18 Years to 75 Years
SexAll
Enrollment40 (estimated)
SponsorChinese University of Hong Kong
Academic / other
Locations1 site (Shatin)
StatusRecruiting
StartedAugust 1, 2026
Main results expectedNovember 1, 2026
Study endsNovember 30, 2026
Registry record updatedOctober 22, 2026
Trial IDNCT07255703 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18-75 years old planned for lobectomy, segmentectomy, wedge resection, or mediastinal tumor resection who are eligible for general anesthesia and meet surgical indications.

Probably not a fit

Patients with prior thoracic surgery, significant comorbidities, or unsuitable anatomy or health status may not experience benefit and could be at higher risk.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the SHURUI single-port surgical robot (SR-ENS-600) used in thoracic and related surgeries. Eligible adults aged 18-75 with resectable lung cancers, oligometastatic lung disease, or mediastinal tumors may undergo endoscopic procedures with the robotic system. The investigation focuses on surgical feasibility, safety, and perioperative outcomes in a real-world clinical setting. Procedures involve limited-incision, single-port access to improve precision and potentially shorten recovery. Data collection includes standard perioperative metrics and patient outcomes, without a specified intervention arm since this is observational.

Why it matters

Potential benefit: If successful, patients may experience less tissue trauma, fewer complications, and faster recovery after thoracic procedures using the SHURUI SP system.

How similar studies have gone: Prior reports suggest single-port robotic approaches can reduce invasiveness and recovery time, though evidence quality varies and this may be among early regional experiences.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria:

1. Age between 18 - 75 years;
2. Subjects need to undergo endoscopic surgery and meet one of the following indications for surgical treatment:

   * Lobectomy, segmentectomy wedge resection of lung: Clinically diagnosed resectable early stage non-small cell lung carcinoma; oligometastatic cancer to the lung;
   * Mediastinal mass resection: Clinically diagnosed mediastinal tumour (benign or malignant) that are indicated for resection;
3. Preoperative ASA grade: Grade I-III;
4. Subject voluntarily participates in the clinical trial, and agrees or his/her guardian agrees and signs the informed consent.

Exclusion criteria:

1. Subjects with a previous history of thoracic surgery or other malignant tumor which, in the judgement of the investigator, make them unsuitable for enrolment;
2. Subjects with severe co-morbidities or organ dysfunction (heart, lung, liver, brain, kidney, etc.) or deemed too weak/ unsuitable for general anesthesia or operation;
3. Non-correctable coagulopathy and severe bleeding tendency;
4. Emergency surgery;
5. Severe obesity with BMI ≥30 kg/m2;
6. Subjects with severe allergic constitution, suspected or confirmed alcohol, drug addiction;
7. Other circumstances in which the investigator considered participation in this clinical trial inappropriate.

Where it's running

  • Prince of Wales Hospital
    Shatin, Hong Kong
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.